Dr. Rebecca Backenroth-maayan, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 15 Mitchill Pl, Pelham, NY 10803 Phone: 617-935-5532 |
News Archive
According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.
Insulin pump therapy contributes to better blood glucose control in type 1 diabetes and, as pump technology continues to improve and become part of sensor-controlled feedback and artificial pancreas systems, essentially all patients would benefit from their capabilities according to a Commentary published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Induced neural stem cells (iNSCs) created from adult cells hold promise for therapeutic transplantation, but their potential in this capacity has been limited by failed efforts to maintain such cells in the desirable multi-potent NSC state without continuous expression of the transcription factors used initially to reprogram them.
NeoMatrix, makers of the HALO Breast Pap Test, is a sponsor of a congressional reception Sept. 9 on Capitol Hill, which will focus on the EARLY Act and raising awareness about young women's breast cancer risk.
› Verified 8 days ago